Clinical Trial

WMT for Autism Spectrum Disorder (ASD)

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Autism Spectrum Disorder (ASD) is a group of serious neurodevelopmental disorders. A significant comorbidity exists between ADHD and ASD: 30%-50% of individuals with ASD exhibit ADHD symptoms, and two-thirds with ADHD show ASD traits. Intestinal microbial disturbance is common in children with ASD. A great deal of evidence shows that intestinal microbes can influence the brain to play its role through "gut-brain-microbiota axis". We intend to explore the role of Washed Microbiota Transplantation in improving symptoms of children in ASD with or without ADHD; To study the potential etiological mechanism of WMT for the neurodevelopmental disorders.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-09-07; most recent amendment 2025-09-03.
Status change: Not Yet Recruiting → Recruiting 2024-04-25
Trial Details
NCT Number NCT06030752
Lead Sponsor The Second Hospital of Nanjing Medical University
Collaborators: Nanjing Medical University
Conditions Autism Spectrum Disorder
Enrollment 80 participants
Start Date 2023-09-20
Primary Completion 2027-04-04 (estimated)
Study Completion 2027-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-05